SANTA CRUZ — Employees at Verve Coffee Roasters voted to unionize Tuesday. On Labor Day, Verve Workers United delivered letters stating their intent to unionize to Verve upper management. Verve did ...

Experian and Verve Group on Tuesday announced their latest collaboration — bringing high-accuracy targeting to ID-less audiences. The collaboration combines Verve’s on-device intelligence with ...

Another search intelligence company has been gobbled up -- this time by Verve Group, the ad-technology company based in Stockholm. Verve will pay a total of €25.6 million for Captify Technologies in ...

Lilly will acquire Verve Therapeutics and a pipeline of one-time treatments for cardiovascular diseases in a deal worth up to US$1.3 billion. "In just seven years, our team has progressed three in ...

Jefferies analysts called the proxy filing, which is a standard disclosure after a merger agreement, “much more intriguing than normal” given the regulatory turmoil it revealed. It’s not every day ...

Eli Lilly’s $1.3 billion acquisition of Verve Therapeutics marks a strategic expansion into cardiovascular genetic medicine. The pharmaceutical giant paid a premium of about 113% over Verve’s 30-day ...

On Tuesday, Eli Lilly And Co (NYSE:LLY) agreed to acquire Verve Therapeutics, Inc. (NASDAQ:VERV), a Boston-based clinical-stage company developing genetic medicines for cardiovascular disease. Lilly ...

Cambridge, MA - July 11: Verve CEO and cofounder Sekar Kathiresan. Cambridge company Verve Therapeutics announced on Tuesday morning that it has dosed the first patient with its new CRISPR gene ...

Eli Lilly & Co. agreed to buy gene-editing biotech company Verve Therapeutics Inc. for $1.3 billion, the drugmaker’s latest investment in an experimental medicine that could fuel its long-term growth.

Eli Lilly LLY-0.60%decrease; red down pointing triangle agreed to acquire Verve Therapeutics for about $1 billion upfront, adding a potential treatment for cardiovascular disease to its portfolio.

Verve Therapeutics VERV signed a definitive agreement with pharma bigwig Eli Lilly LLY. Per the terms, the pharma giant will acquire all outstanding shares of VERV for $10.50 per share in cash, ...